Chemotherapy-induced peripheral neurotoxicity (Q35925635)

11 August 2017

1 reference

title

Chemotherapy-induced peripheral neurotoxicity. (English)

1 reference

11 August 2017

1 reference

1 reference

Guido Cavaletti

1

0 references

author name string

Paola Marmiroli

series ordinal

2

1 reference

PubMed ID

15500413

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Drug Safety

11 August 2017

1 reference

11 August 2017

3

1 reference

11 August 2017

6

1 reference

11 August 2017

535-546

1 reference

Chemotherapeutic neuropathy

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Toxicity of platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Oxaliplatin: a review of preclinical and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Oxaliplatin: a review of its use in the management of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

An electrophysiological investigation of the effects of cisplatin and the protective actions of dexamethasone on cultured dorsal root ganglion neurones from neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Carboplatin toxic effects on the peripheral nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Acute oxaliplatin-induced peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-deriv

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Vincristine neuropathy: an electrophysiological and histological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Suramin, a novel antitumor compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Calcium in suramin-induced rat sensory neuron toxicity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Suramin-induced polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

A prospective study of suramin-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Evaluation of neuropathy in patients on suramin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Suramin-induced neuropathy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Thalidomide neuropathy in patients treated for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Thalidomide-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Thalidomide-induced neuropathy: a ganglionopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

The role of glutathione in combination with cisplatin in the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Grading of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Pitfalls in electrodiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Toxic neuropathy in patients with pre-existing neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

Protective effects of glutathione on cisplatin neurotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.6.535

21 January 2018

Identifiers

DOI

10.1517/14740338.3.6.535

1 reference

11 August 2017

1 reference

PubMed ID

15500413